Study of Comparative Effectiveness of Prucalopride and Lubiprostone in Constipation Predominant Irritable Bowel Syndrome
NCT04985669
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
140
Enrollment
OTHER
Sponsor class
Conditions
Patient Satisfaction
Interventions
DRUG:
Prucalopride 2mg
Sponsor
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh